Filtrer vos résultats
- 4
- 4
- 3
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
4 résultats
|
|
|
triés par
|
|
|
Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasisVaccine: X, 2023, 15, pp.100403. ⟨10.1016/j.jvacx.2023.100403⟩
Article dans une revue
hal-04273054v1
|
||
|
|
A review of current treatments strategies based on paromomycin for leishmaniasisJournal of Drug Delivery Science and Technology, 2020, 57, pp.101664. ⟨10.1016/j.jddst.2020.101664⟩
Article dans une revue
hal-02502802v1
|
||
|
|
Intranasal immunization with chitosan microparticles enhances lack-dna vaccine protection and induces specific long-lasting immunity against visceral leishmaniasisMicrobes and Infection, 2022, 24 (2), pp.104884. ⟨10.1016/j.micinf.2021.104884⟩
Article dans une revue
hal-03338952v1
|
||
|
|
Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric PopulationsPharmaceutics, 2021, 13 (8), pp.1-19/1114. ⟨10.3390/pharmaceutics13081114⟩
Article dans une revue
hal-03296974v1
|